SEARCH

SEARCH BY CITATION

References

  • ARNAULD, E., ARSAUT, J. & DEMOTES-MAINARD, J. (1993). Functional heterogeneity of the caudate-putamen as revealed by c-fos induction in response to D1 receptor activation. Mol. Brain Res., 18, 339342.
  • BATTAGLIA, G., NORMAN, A.B., HESS, E.J. & CREESE, I. (1986). Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors. Neurosci. Lett., 69, 290295.
  • BHAT, R.V. & BARABAN, J.M. (1993). Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J. Pharmacol Exp. Ther., 267, 496505.
  • BHAT, R.V., COLE, A.J. & BARABAN, J.M. (1992). Role of monoamine systems in activation of zif268 by cocaine. J. Psychiat. Neurosci., 17, 94102.
  • BUONAMICI, M., CERVINI, M.A., MAJ, R., MANTEGANI, S. & ROSSI, A.C. (1992). A new dopamine agonist in dopamine deprived systems: FCE 23884. Neurochem. Int., 20, Suppl., 179S183S.
  • BUONAMICI, M., MANTEGANI, S., CERVINI, M.A., MAJ, R., ROSSI, A.C, CACCIA, C., CARFAGNA, N., CARMINATI, P. & FARIELLO, R.G. (1991). FCE 23884, substrate-dependent interaction with the dopaminergic system. I. Preclinical behavioral studies. J. Pharmacol. Exp. Ther., 259, 345355.
  • CARFAGNA, N., CACCIA, C., MANTEGANI, S., CAVANUS, S., FORNARETTO, M.G., BUONAMICI, M., ROSSI, A.C, RONCUCCI, R. & FARIELLO, R.G. (1991). FCE 23884, substrate-dependent interaction with the dopaminergic system. II. Preclinical biochemical studies. J. Pharmacol. Exp. Ther., 259, 356364.
  • CURRAN, T., GORDON, M.B. & SAMBUCETTI, L.C. (1987). Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro. Oncogene, 2, 7984.
  • DRAGUNOW, M., ROBERTSON, G.S., FAULL, R.L., ROBERTSON, H.A. & JANSEN, K. (1990). D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience, 37, 287294.
  • FINK-JENSEN, A. & KRISTENSEN, P. (1994). Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain. Neurosci. Lett., 182, 115118.
  • GERBER, R., ALTAR, C.A. & LIEBMAN, J.M. (1988). Rotational behaviour induced by 8-hydroxy-DPAT, a putative 5HT1A agonist, in 6-hydroxydopamine-lesioned rats. Psychopharmacology, 94, 178182.
  • GERFEN, C.R., ENGBER, T.M., MAHAN, L.C, SUSEL, Z., CHASE, T.N. Jr, MONSMA, F.J. & SIBLEY, D.R. (1990). D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science, 250, 14291432.
  • GREENE, P., COTE, L. & FAHN, S. (1993). Treatment of drug-induced psychosis in Parkinson's disease with clozapine. Adv. Neurol., 60, 703706.
  • GRIMA, B., LAMOROUX, A., BLANOT, F., BIQUET, N.F. & MALLET, J. (1985). Complete coding sequence of rat tyrosine hydroxylase mRNA. Proc. Natl. Acad. Sci. U.S.A., 82, 617621.
  • HU, K.T., WACHTEL, S.R., GALLOWAY, M.P. & WHITE, F.J. (1990). Lesions of the nigrostriatal projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 from the necessity of D1 receptor stimulation. J. Neurosci., 10, 23182329.
  • KAHN, R.S. & DAVIS, K.L. (1995). New developments in dopamine and schizophrenia. In Psychopharmacology: the Fourth Generation of Progress, ed. Bloom, F.E. & Kupfer, D.J. pp. 11931203. New York: Raven Press.
  • KLUG, J.M. & NORMAN, A.B. (1993). Long-term sensitization of apomorphine-induced rotation behaviour in rats with dopamine deafferentation or excitotoxin lesions of the striatum. Pharmacol. Biochem. Behav., 46, 397403.
  • KONRADI, C., KOBIERSKI, L.A., NGUYEN, T.V., HECKERS, S. & HYMAN, S.E. (1993). The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. Proc. Natl. Acad. Sci. U.S.A., 90, 70057009.
  • KRISCH, I., BOLE-VUNDUK, B., LAVRIC, B., OCVIRK, A., PEPELNAK, M., BUDIHNA, M.V. & SKET, D. (1994). Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841. J. Pharmacol. Exp. Ther., 271, 343352.
  • LE MOINE, C., NORMAND, E. & BLOCH, B. (1991). Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. Natl. Acad. Sci. U.S.A., 88, 42054209.
  • LE MOINE, C., NORMAND, E., GUITTENY, A.F., FOUQUE, B., TEOULE, R. & BLOCH, B. (1990). Dopamine receptor gene expression by enkephaline neurons in rat forebrain. Proc. Natl. Acad. Sci. U.S.A., 87, 230234.
  • MACGIBBON, G.A., LAWLOR, P.A., BRAVO, R. & DRAGUNOW, M. (1994). Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol. Brain Res., 23, 2132.
  • MARKSTEIN, R., ENZ, A., VIGOURET, J.M., JATON, A., CLOSSE, A., BRINER, U. & GULL, P. (1987). Biochemical, behavioural, and endocrine effects of CK 204–933, a novel 8-ergolene. J. Neural Transm., 6, 179199.
  • MARKSTEIN, R., SEILER, M.P., JATON, A. & BRINER, U. (1992). Structure activity relationship and therapeutic uses of dopamine ergot. Neurochem. Int., 20, Suppl., 211S214S.
  • MERCHANT, K.M. & DORSA, D.M. (1993). Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc. Natl. Acad. Sci. U.S.A., 90, 34473451.
  • MILLER, J.C. (1990). Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J. Neurochem., 54, 14531455.
  • MORELLI, F., FENU, S., GARAU, L. & DICHIARA, G. (1989). Time and dose dependence of the ‘priming’ of the expression of dopamine receptor supersensitivity. Eur. J. Pharmacol., 162, 329335.
  • NGUYEN, T.V., KOSOFSKY, B.E., BIRNBAUM, R., COHEN, B.M. & HYMAN, S.E. (1992). Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. U.S.A., 89, 42704274.
  • PAUL, M.L., GRAYBIEL, A.M., DAVID, J. C. & ROBERTSON, H.A. (1992). D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci., 12, 37293742.
  • ROBERTSON, G.S. & FIBIGER, H.C. (1992). Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience, 46, 315328.
  • ROBERTSON, G.S., MATSMURA, H. & FIBIGER, H.C. (1994). Induction patterns of fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J. Pharmacol. Exp. Ther., 271, 10581066.
  • ROBERTSON, G.S., VINCENT, S.R. & FIBIGER, H.C. (1992). D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience, 49, 285296.
  • ROBERTSON, G.S. & ROBERTSON, H.A. (1986). Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats. Brain Res., 384, 387390.
  • ROBERTSON, H.A., PETERSON, M.R., MURPHY, K. & ROBERTSON, G.S. (1989). D1 dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Res., 503, 346349.
  • ROGUE, P. & VINCENDON G. (1992). Dopamine D2 receptor antagonists induce immediate early genes in the rat striatum. Brain Res. Bull., 29, 469472.
  • SIRINATHSINGHJI, D.J.S., MORRIS, B.J., WISDEN, W., NORTHROP, A., HUNT, S.P. & DUNNET, S.B. (1990). Gene expression in striatal grafts - I. Cellular localization of neurotransmitter mRNA's. Neuroscience, 34, 675686.
  • SIRINATHSINGHJI, D.J.S., SCHULIGOI, R., HEAVENS, R.P., DIXON, A., IVERSEN, S.D. & HILL, R.G. (1994). Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine receptor antagonist. Neuroscience, 62, 407423.
  • SONSALLA, P.K., MANZINO, L. & HEIKKILA, R.E. (1988). Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. J. Pharmacol. Exp. Ther., 247, 180185.
  • TEMLETT, J.A., QUINN, N.P., JENNER, P.G., MARSDEN, C.D., POURCHER, E., BONNET, A.M., AGID, Y., MARKSTEIN, R. & LATASTE, X. (1989). Antiparkinsonian activity of CY 208–243, a partial D1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease. Movement Disorders, 4, 261265.
  • UNGERSTEDT, U. (1971a). Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta Physiol. Scand. Suppl. 367, 6993.
  • UNGERSTEDT, U. (1971b). Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol. Scand. Suppl 367, 4968.
  • WADDINGTON, J.L. (1993). Future directions: The clinical significance and the therapeutic potential of D1:D2 interactions in Parkinson's disease, schizophrenia and other disorders. In D1.D2 Dopamine Receptor Interactions, ed. Waddington, J.L. pp. 271290. London: Academic Press.
  • WADDINGTON, J.L. & DALY, S.A. (1993). Regulation of unconditioned motor behaviour by D1:D2 interactions. In D1:D2 Dopamine Receptor Interactions, ed. Waddington, J.L. pp. 5178. London: Academic Press.
  • WATTS, V.J., LAWLER, C.P., GONZALES, A.J., ZHOU, Q. Y., CIVELLI, O., NICHOLS, D.E. & MAILMAN, R.B. (1995). Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonists. Synapse, 21, 177187.
  • WISDEN, W., MORRIS, B.J. & HUNT, S.P. (1991). In situ hybridization with synthetic DNA probes. In Molecular Neurobiology, ed. Chad, J. & Wheal, H. pp. 205225. Oxford: Oxford University Press.